SEARCH RESULTS

331009 RESULTS

Symposium on New Treatments for Dementia

CONFERENCE 2005-03-10 00:00:00-2005-03-10 00:00:00 New York Academy of Medicine, New York, NY, U.S.A. 10 March 2005 Journalists are welcome to attend a symposium with a comprehensive approach to the latest treatments for dementia. It will focus on the best medicines, new ways to collaborate with family me

Challenging Views Satellite Debate

CONFERENCE 2005-03-09 00:00:00-2005-03-09 00:00:00 Hilton Sorrento Palace- Tritone Room, Sorrento, Italy 09 March 2005 It is our pleasure to invite you to participate in a unique satellite meeting to be held in conjunction with the AD/PD conference in Sorrento, Italy. The one-day meeting will take place o

PSEN1 Y154N

MUTATIONS PSEN1 73640395 GRCh37/hg19 rs63750588 T A g.25663T> A g.42217T> A Exon 5 Point, Missense Coding Dramatically decreased Aβ40 and Aβ42 production, as well as decreased endopeptidase activity, in vitro. Unknown, MRI and SPECT showed atrophy and hypoper

PSEN1 L153V

MUTATIONS PSEN1 73640392 GRCh37/hg19 rs63751441 C G g.25660C> G g.42214C> G Exon 5 Point, Missense Coding Decreased Aβ40 and Aβ42 production in vitro. Neuropathology consistent with AD in one case.  L153V Alzheimer's Disease: PathogenicAlzheimer's D

PSEN1 T147I

MUTATIONS PSEN1 73640375 GRCh37/hg19 rs63750907 C T g.25643C> T g.42197C> T Exon 5 Point, Missense Coding Unknown; predicted probably damaging in silico. Unknown. T147I Alzheimer's Disease: PathogenicAlzheimer's Disease This mutation was detected in

International AD/PD Satellite Symposium, 2005

CONFERENCE 2005-03-08 00:00:00-2005-03-08 00:00:00 University of Naples, Naples, Italy 08 March 2005 On the occasion of the 7th International AD/PD Conference in Sorrento, Italy, March 9-13, 2005, the APOPIS consortium will arrange for a satellite symposium to present their first-year results. The satelli

Neurodegenerative Drug Development Forum

CONFERENCE 2005-03-07 00:00:00-2005-03-08 00:00:00 Central London, United Kingdom 07 &#x2013 08 March 2005 Key Topics: Considerations for end product enhancement Pricing and reimbursement issues examined through case studies Clinical challenges in drug development Commercial realitites in drug develop

Cellular Senescence and Cell Death (J7)

CONFERENCE 2005-03-03 00:00:00-2005-03-09 00:00:00 Keystone Resort, Keystone, CO, U.S.A. 03 &#x2013 09 March 2005 When we consider the enormous number of cells that proliferate in an individual over the course of a lifetime, cancer is a remarkably rare occurrence. Two major and general checks on carci

ASENT: 2005 Annual Meeting

CONFERENCE 2005-03-03 00:00:00-2005-03-05 00:00:00 Omni Shoreham Hotel, Washington, DC, U.S.A. 03 &#x2013 05 March 2005 This Seventh Annual Meeting of ASENT presents two plenary symposia and three specialized workshops on topics of timely interest for investigators and other professionals interested i

Old Age Psychiatry Annual Conference

CONFERENCE 2005-05-02 00:00:00-2005-05-04 00:00:00 Okura Hotel, Amsterdam, Amsterdam, Netherlands 02 &#x2013 04 May 2005 View Conference Website 0

Diagnostic Imaging, Tools to Advance Pharmaceutical Drug Development

CONFERENCE 2005-03-01 00:00:00-2005-03-02 00:00:00 Renaissance, Washington, DC, U.S.A. 01 &#x2013 02 March 2005 This conference brings together experts from industry, academia and government involved in all areas of imaging: The how, why and when to apply, implement, assess or outsource imaging. This

Ubiquitin and Signaling (B7)

CONFERENCE 2005-02-22 00:00:00-2005-02-25 00:00:00 Taos Convention Center, Taos, NM, U.S.A. 22 &#x2013 25 February 2005 Our understanding of how ubiquitin regulates cellular function has greatly expanded recently, spurred by discoveries of protein families involved in ubiquitin conjugation and de-conj

Current Filters

No filters selected

Filter By

DATE RANGE
  • All
  • Past 7 Days
  • Past 30 Days
  • Past 90 Days
  • Past 12 Months
  • Specific Dates
    1. From
      To

TYPE